HomeCompareTEGS vs JNJ

TEGS vs JNJ: Dividend Comparison 2026

TEGS yields 27.55% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TEGS wins by $94.8K in total portfolio value
10 years
TEGS
TEGS
● Live price
27.55%
Share price
$7.26
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$114.8K
Annual income
$14,100.03
Full TEGS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TEGS vs JNJ

📍 TEGS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTEGSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TEGS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TEGS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TEGS
Annual income on $10K today (after 15% tax)
$2,341.60/yr
After 10yr DRIP, annual income (after tax)
$11,985.03/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TEGS beats the other by $11,281.41/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TEGS + JNJ for your $10,000?

TEGS: 50%JNJ: 50%
100% JNJ50/50100% TEGS
Portfolio after 10yr
$67.4K
Annual income
$7,463.91/yr
Blended yield
11.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TEGS
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TEGS buys
0
JNJ buys
0
No recent congressional trades found for TEGS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTEGSJNJ
Forward yield27.55%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$114.8K$20.0K
Annual income after 10y$14,100.03$827.78
Total dividends collected$75.7K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TEGS vs JNJ ($10,000, DRIP)

YearTEGS PortfolioTEGS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,455$2,754.82$10,676$355.77+$2.8KTEGS
2$17,861$3,464.08$11,407$389.39+$6.5KTEGS
3$23,409$4,297.59$12,198$426.53+$11.2KTEGS
4$30,311$5,264.01$13,056$467.62+$17.3KTEGS
5$38,803$6,370.32$13,987$513.12+$24.8KTEGS
6$49,141$7,621.55$14,998$563.56+$34.1KTEGS
7$61,602$9,020.60$16,098$619.52+$45.5KTEGS
8$76,482$10,568.14$17,295$681.69+$59.2KTEGS
9$94,098$12,262.56$18,599$750.82+$75.5KTEGS
10$114,785$14,100.03$20,022$827.78+$94.8KTEGS

TEGS vs JNJ: Complete Analysis 2026

TEGSStock

The fund will under normal conditions invest at least 80% of its net assets (plus borrowings for investment purposes) directly, or indirectly through mutual funds or exchange traded funds, in equity or fixed income securities of well-known environmental, social, and governance ("ESG") indices such as MSCI and Russell. It may also invest up to 20% of its net assets in cash and cash equivalents including U.S. government securities.

Full TEGS Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TEGS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TEGS vs SCHDTEGS vs JEPITEGS vs OTEGS vs KOTEGS vs MAINTEGS vs ABBVTEGS vs MRKTEGS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.